IMMUNE-MEDIATED CHOLANGITIS

This adverse event was reported 359 times

These drugs are most commonly taken by patients reporting IMMUNE-MEDIATED CHOLANGITIS:

# Drug Count
0 NIVOLUMAB 158
1 PEMBROLIZUMAB 150
2 IPILIMUMAB 67
3 CARBOPLATIN 54
4 PACLITAXEL 33
5 PEMETREXED DISODIUM 31
6 PACLITAXEL (AIBUMIN-BOUND) 28
7 CISPLATIN 27
8 DURVALUMAB 23
9 ACETAMINOPHEN 22
See all common drugs associated with IMMUNE-MEDIATED CHOLANGITIS